Qiagen Officials Talk TB Test, GeneReader Opportunities at Piper Jaffray Conference | GenomeWeb

NEW YORK (GenomeWeb Daily News) — Speaking at Piper Jaffray's annual healthcare conference today, members of Qiagen's management team provided investors with a recap of recent business activities and a glimpse of what's to come.

Qiagen CFO Roland Sackers told investors that the firm saw "very nice underlying growth" from its molecular diagnostics and applied testing businesses in 2013, with "stabilization" in its pharmaceutical/life sciences research products business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.